Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 115047
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.115047
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.115047
Table 1 Differentiation between plasmapheresis (therapeutic plasma exchange) and hemodialysis[15]
| Characteristic | Hemodialysis | TPE-membrane filtration | TPE-centrifugation |
| Mechanism | Diffusion and/or convection | Convection | Centrifugal force |
| Blood flow, mL/minute | Continuous: 100-300; intermittent: 200 > 400 | 150-200 | 10-150 |
| Blood volume in circuit, mL | 160-280 | 125 | 180 |
| Plasma extraction, % | N/A | 30 | 80 |
| Molecular weight cutoff, Da | < 15000 | > 15000 | > 15000 |
| Vd, L/kg | Moderate (≤ 1.5-2) | Low (< 0.3) | Low (< 0.3) |
| Protein binding, % | < 80 | > 80 | > 80 |
| Anticoagulation | Heparin | Heparin | Citrate |
| Sterilisation | Ethylene oxide; steam; electron beam; γ-irradiation | γ-irradiation; ethylene oxide | γ-irradiation; ethylene oxide |
- Citation: Manrai M, Pachisia AV, Dawra S, Shukla S, Jha AA. Navigating the therapeutic tightrope: Precision use of plasmapheresis and continuous renal replacement therapy in liver failure. World J Hepatol 2026; 18(5): 115047
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/115047.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.115047